OMass Therapeutics

PITCH
Harnessing proprietary biochemistry, native mass spectrometry and custom chemistry to interrogate not just the target but how it interacts with its native ecosystem, separate from the confounding complexity of the cell
LATEST INVESTMENT
#Biotech
05.2023
£10M
British Patient Capita